TrialHuman vaccines & immunotherapeutics2022

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial.

Dandan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.